mRNA vaccines

Pfizer pulls ahead in the race to develop an mRNA influenza vaccine – but some questions remain

mRNA flu shot far more effective than current vaccine – but there are issues

In a Phase 3 trial of more than 18,000 volunteers across three countries, a novel mRNA influenza vaccine developed by Pfizer has outperformed standard seasonal flu shots by 34.5%. It's yet another sign that this biotechnology is here to stay.

Unit-per-unit, the experimental nanoparticle-enhanced mRNA vaccine reportedly does the work of a hundred times as much of its FDA-approved equivalent

Medical Innovations

New nanoparticle mRNA vaccine may be cheaper and 100 times more powerful

Researchers at MIT have just developed a new lipid nanoparticle that super-enhances the effectiveness of the mRNA vaccine in mice to a hundred times its stand-alone effectiveness, reducing required dosages while also reducing toxicity in the liver.

Getting an mRNA COVID-19 vaccine can boost the effectiveness of cancer immune therapy

Illnesses and conditions

mRNA COVID vaccine during cancer therapy linked to 2x survival rate

Getting a COVID shot might do more than protect against the virus – it could also help cancer patients live longer. A new study found that mRNA vaccines were linked to a doubling in three-year survival for those on immunotherapy.